Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016

Be the first to review this product

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Cardiac Resynchronisation Therapy -...
You can choose to pay by purchase order during checkout

Availability: In stock

$2,500.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016' provides an overview of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 65
Publication date 1 Jun 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Overview 6
3 Products under Development 7
3.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development 7
3.2 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment 8
3.3 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory 9
3.4 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path 10
3.5 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date 11
3.6 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials 12
4 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products under Development by Companies 13
4.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development 13
4.2 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development 14
5 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies and Product Overview 15
5.1 Boston Scientific Corporation Company Overview 15
5.1.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 John Hopkins University Company Overview 20
5.2.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 LivaNova PLC Company Overview 22
5.3.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Medtronic plc Company Overview 28
5.4.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 28
5.5 Sorin Group Italia S.r.l Company Overview 30
5.5.1 Sorin Group Italia S.r.l Pipeline Products & Ongoing Clinical Trials Overview 30
5.6 St. Jude Medical, Inc. Company Overview 33
5.6.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.7 TransWorld Med Corporation Company Overview 37
5.7.1 TransWorld Med Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
6 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D)- Recent Developments 38
6.1 May 16, 2016: Heart Hospital of Austin First in Texas to Offer MultiPoint Pacing Technology for Heart Failure Patients 38
6.2 May 05, 2016: SonR: 35% Risk Reduction in Heart Failure Hospitalization 38
6.3 May 04, 2016: Overlake Becomes First Hospital in Washington to Offer MultiPoint Pacing Technology for Heart Failure Patients 40
6.4 Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016 40
6.5 Apr 26, 2016: Allied 100 Acquires Lifeguard Medical Solutions 42
6.6 Apr 18, 2016: St. Jude Medical Announces Launch And First US Implants Of MultiPoint Pacing Technology 42
6.7 Apr 13, 2016: Nihon Kohden Evolves Brand, Website to Meet Needs of Changing Healthcare Environment 43
6.8 Apr 08, 2016: Lankenau Heart Institute at Paoli Hospital has Implanted the Region's First MRI-Safe Cardiac Resynchronization Defibrillator 44
6.9 Apr 05, 2016: St. Jude Medical Announces MHLW Approval for MRI Conditional Labeling on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients 44
6.10 Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors 45
6.11 Feb 22, 2016: Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans 46
6.12 Feb 05, 2016: Medtronic's Amplia MRI Quad CRT-D SureScan System Receives FDA Approval for Treatment of Heart Failure 47
6.13 Feb 05, 2016: Medtronic's Compia MRI Quad CRT-D SureScan System Receives FDA Approval For Treatment Of Heart Failure 48
6.14 Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015 49
6.15 Feb 03, 2016: Nihon Kohden America Receives Great Place to Work Certification 50
6.16 Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence 50
6.17 Dec 10, 2015: BIOTRONIK Announces Start of New Study Evaluating whether Pacemakers with Closed Loop Stimulation Prevent Reflex Syncope 51
6.18 Dec 02, 2015: St. Jude Medical Announces CE Mark for MRI Compatibility on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients 51
6.19 Dec 01, 2015: BIOTRONIK Announces Start of Study to Evaluate Benefits of Unique Rate Response Algorithm for Atrial Fibrillation Patients 52
6.20 Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015 53
6.21 Aug 25, 2015: BIOTRONIK presents its CRT-Ds Approved for Full-Body MRI Scanning at ESC Congress 2015 54
6.22 Aug 24, 2015: Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems 54
6.23 Aug 05, 2015: BIOTRONIK Announces Start of First Study to Assess Relevance of Defibrillator Back-Up after CRT-D Replacement 55
6.24 Jul 31, 2015: Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2016 56
6.25 Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators 57
6.26 Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators 58
6.27 Jul 23, 2015: Boston Scientific Announces Results For Second Quarter 2015 58
6.28 Jul 16, 2015: ZOLL Announces Release of Its CPR Extract Capability 59
6.29 Jul 02, 2015: BIOTRONIK Announces Start of Pioneering BIOWOMEN Study 60
6.30 Jun 22, 2015: Boston Scientific Begins EMBLEM Defibrillator Study In Sudden Cardiac Death 60
6.31 Jun 16, 2015: Hill-Rom Acquires Welch Allyn for USD2.05 Billion 61
7 Appendix 62
7.1 Methodology 62
7.2 About GlobalData 64
7.3 Contact Us 65
7.4 Disclaimer 65

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.